Botanical treatment holds hope for triple-negative breast cancer

Published on October 29, 2012 at 12:26 PM · No Comments

A unique formula made from medicinal mushrooms, traditional Chinese herbs and other natural ingredients inhibits aggressive, human triple-negative breast cancer and breast-to-lung metastasis in mice. This is the third peer-reviewed study to demonstrate the botanical formula's anticancer effects.

The formula decreases metastasis, slows cancer growth and suppresses a number of pro-cancer genes, with no signs of toxicity. This study was conducted at the Cancer Research Laboratory, Methodist Research Institute, Indiana University Health. Results were published in the October 2012 issue of Oncology Reports.

"Patients with triple-negative breast cancer often die from metastasis," says study co-author Isaac Eliaz, M.D. "This formula, taken as a health supplement, may offer new hope for patients struggling to overcome an invasive, deadly disease which has been so difficult to treat."

Powerful Botanical Combination
The formula succeeds by hitting cancer with a powerful combination therapy. Medicinal mushrooms Trametes versicolor, Ganoderma lucidum and Phellinus linteus are shown to reduce cancer growth and invasiveness. Concentrated extracts from the botanicals Scutellaria barbata, Astragalus membranaceus and Curcuma longa induce programmed cell death (apoptosis) and can reduce cancer metastasis. The flavonoid, quercetin, reduces cancer cell proliferation and suppresses tumor growth. DIM (3, 3'-Diindolylmethane), an active component derived from eating cruciferous vegetables, reduces cancer growth, migration and invasiveness. (To learn more about the formula visit www.BreastHealthFormula.org)

In the study, cancer metastasized to the lungs in only 20 percent of treated mice compared to 70 percent of the untreated mice. Study authors also emphasize that in the treated mice that did show metastasis, the number and size of the metastatic lesions was dramatically reduced compared to the untreated group.

Gene analysis showed that the formula suppressed two genes implicated in breast cancer metastasis—PLAU and CXCR4. These results confirm previous in vitro studies, in which the formula also down-regulated these cancer-promoting genes.

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post